Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the period ending September 2012. The report details a specific corporate action regarding share repurchases executed on September 4, 2012, in accordance with shareholder authority granted at the Annual General Meeting on May 3, 2012.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on capital structure changes related to share buybacks.
- Shares Purchased: 1,673,500 Ordinary Shares of 25 pence each.
- Purchase Price Range: Highest price paid was 1,437.50 pence per share; lowest price paid was 1,412.50 pence per share.
- Treasury Holdings (Settled): 501,408,927 shares, representing 9.16% of total issued share capital.
- Treasury Holdings (Including Unsettled): 506,282,427 shares, representing 10.19% of current total voting rights.
- Shares in Issue (Excluding Treasury): 4,970,843,782 shares.
Material Changes
The primary material change reported is the reduction of outstanding shares through the purchase of 1,673,500 shares for treasury. This action increased the percentage of total voting rights held in treasury from the prior level to 10.19% when including unsettled purchases.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, management commentary on operations, or discussion of risks and contingencies. It is a compliance disclosure under the Financial Services Authority's Disclosure and Transparency Rules regarding share ownership thresholds.
Investor Verification Checklist
- Verify the total number of shares held in treasury (501,408,927 settled) against the company's latest capitalization table.
- Confirm the calculation of voting rights (10.19%) based on the 4,970,843,782 shares in issue.
- Check subsequent filings for the settlement status of the 4,873,500 shares purchased but not yet settled at the time of this report.
- Review the Annual General Meeting minutes from May 3, 2012, to confirm the remaining authority for future share repurchases.